Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 361 (RNA5SP361) is a human processed pseudogene related to the 5S ribosomal RNA gene family[2][4]. By definition, processed pseudogenes originate by retrotransposition of mRNA transcripts, resulting in DNA sequences that typically lack introns and can be integrated at new genomic loci[4]. They usually lack promoters and are not efficiently transcribed or translated into functional molecules. Most pseudogenes, including RNA5SP361, do not encode proteins or functional RNAs and are not involved in classical molecular signaling, transport, or enzymatic activities, but global pseudogene expression patterns can serve as biomarkers in fields such as cancer research[6]. There is no evidence that RNA5SP361 is itself a therapeutic target or has clinical relevance as an individual entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 361 (RNA5SP361).